Product: Precision Insights

Filter

Thought Leadership

Product

Organization

Precision Insights
NantHealth Presents Research Demonstrating Real World Evidence of Simultaneous Presentation and Publication of Oncology Data at the 2019 San Antonio...
Eviti Connect study showed an increase in clinical uptake of practice-changing data San Antonio, TX – December 11, 2019 –...
Precision Insights
Precision Insights
NantHealth Announces FDA Marketing Authorization of Omics CoreSM: The Nation’s First Tumor-Normal Mutation Profiling of Overall Tumor Mutational Burden from...
Landmark FDA clearance of whole exome sequencing in vitro diagnostic (IVD) test reporting overall tumor mutation burden (TMB) by sequencing...
Precision Insights
Precision Insights
NantHealth® and NantOmics to Present Evidence for Selective Silencing of MHC-Binding NE Oepitopes to Avoid Immune Surveillance
Results to be presented during the developmental immunotherapy and tumor immunobiology session at the American Society of Clinical Oncology (ASCO)...
Precision Insights
Precision Insights
NantHealth® and NantOmics to Present Data on Tumor Mutation Burden (TMB) and PD-L1 Expression in SDH/FH Mutated Solid Tumors at...
Results to be presented during the cancer prevention, hereditary genetics and epidemiology session at the ASCO 2019 Annual Meeting CHICAGO,...
Precision Insights
Precision Insights
NantHealth® and Northwest Firefighters Benefits Trust (NWFFT) Join Forces to Provide GPS Cancer® and Liquid GPS to Trust Covered Members
Culver City, CA – March 18, 2019 – NantHealth, Inc. (NASDAQ: NH),announced an agreement with Northwest Fire Fighters Benefits Trust (NWFFT), one...
Precision Insights
Precision Insights
NantHealth® and NantOmics to Reveal New Research Demonstrating Importance of Examining RNA Expression and Individual Biomarkers in Cancer Testing
Findings to be presented at the 2019 American Society of Clinical Oncology’s Genitourinary Cancers Symposium San Francisco and Culver City,...
Precision Insights
Precision Insights
NantHealth® and NantOmics to Reveal New Research at the American Society of Clinical Oncology’s Gastrointestinal Cancers Symposium
Findings demonstrate the need for comprehensive personalized tumor testing to deliver actionable insights and inform effective treatment plans  San Francisco,...
Precision Insights
Precision Insights
NantCell Announces New Celgene Investment
Immunotherapy Company Will Present Findings at the JP Morgan Healthcare Conference in San Francisco on January 7th Second Round Crossover Funding...
Precision Insights
Precision Insights
NantHealth® to Present New Research Findings at the San Antonio Breast Cancer Symposium
Topics to include DNA and RNA profiling and next-generation sequencing of tumors San Antonio, TX – Dec 3, 2018 –...
Precision Insights